Furthermore, antifungal agents supplement reverse systems inflammation, a causal link between insulin resistance, obesity and diabetes, as indicated by the alleviated plasma TNF-α and LPS level (Fig. 1m, n). This evidence concerns the gene TNF and diabetes mellitus.